Top of page
Global Site Navigation

Staff

Local Section Navigation
You are here: Main Content

Clinical Associate Professor Colin Tang

Adjunct Associate Professor

Staff Member Details
Email: c.tang@ecu.edu.au
ORCID iD: https://orcid.org/0000-0002-4643-0466

Associate Professor Colin Tang is a radiation oncologist and Adjunct Associate Professor at ECU’s Exercise Medicine Research Institute.

Background

Clinical Associate Professor, Dr Colin Tang – MBBS, FRANZCR – is a senior radiation oncologist at Sir Charles Gairdner Hospital, the largest public metropolitan hospital in Western Australia. Dr Tang works across most malignancies, though has a high case load and research output in prostate and bladder cancer. He is also the lead radiation oncologist of the Head and Neck Cancer multidisciplinary team and has a high case-load of Head and Neck cancer patients. Dr Tang’s research and clinical practice include genitourinary cancers (focusing on prostate and bladder cancers), gastrointestinal cancers, head and neck cancers, and Cyber Knife.

Prior to his appointment at Sir Charles Gairdner Hospital, Dr Tang was a consultant radiation oncologist at Calvary Mater Hospital in New South Wales after completing his fellowship in Toronto, Canada. In recognition of his commitment to clinical research, particularly in Head and Neck Cancers and Prostate Cancer, he has received >$2.2 million AUD in competitive funding; >15 research grants, >25 refereed journal articles; and 1 book chapter in medical and clinical journals both nationally and internationally.

Professional Associations

  • Medical Board of Australia (MED0001207542)
  • Royal Australian and New Zealand College of Radiologists (Faculty of Radiation Oncology)
  • Trans-Tasman Radiation Oncology Group (TROG)
  • Faculty of Radiation Oncology Genito-Urinary Special Interest Groups (FROGG)
  • Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
  • Australian & New Zealand Head & Neck Society (ANZHNS)
  • Australasian Gastro-Intestinal Trials Group (AGITG)
  • Australia and New Zealand Melanoma Trials Group (ANZMTG)
  • Radiosurgery Society (RSS)

Research Areas and Interests

  • Prostate Cancer
  • Bladder Cancer
  • Head and Neck Cancer
  • Radiation Oncology
  • Lung Cancer
  • CyberKnife
  • Exercise Oncology
  • Survivorship

Research Outputs

Journal Articles

  • Luo, H., Galvao, D., Newton, R., Tang, C., Spry, N., Taaffe, D. (2023). Multimodal Exercise in Older Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy: A Case Series Examining Feasibility and Preliminary Efficacy. European Journal of Cancer Care, 2023(Article in press), Article number 1179848. https://doi.org/10.1155/2023/1179848.
  • Lopez Da Cruz, P., Taaffe, D., Newton, R., Spry, N., Joseph, D., Tang, C., Buffart, L., Galvao, D. (2023). Reporting Attendance and Resistance Exercise Compliance in Men with Localized Prostate Cancer. Medicine and Science in Sports and Exercise, 55(3), 354-364. https://doi.org/10.1249/MSS.0000000000003069.
  • Luo, H., Galvao, D., Newton, R., Tang, C., Hart, N., Singh, F., Dean, A., Jasas, K., Johansson, M., Yusoff, I., Spry, N., Taaffe, D. (2023). Evaluation of a Clinic-Based Exercise Program in Patients with Pancreatic Cancer Undergoing Nonsurgical Treatment. Medicine and Science in Sports and Exercise, 55(1), 9-19. https://doi.org/10.1249/MSS.0000000000003019.

Journal Articles

  • Van Gysen, K., Kneebone, A., Le, A., Wu, K., Haworth, A., Bromley, R., Hruby, G., O'Toole, J., Booth, J., Brown, C., Pearse, M., Sidhom, M., Wiltshire, K., Tang, C., Eade, T. (2022). Evaluating the utility of knowledge-based planning for clinical trials using the TROG 08.03 post prostatectomy radiation therapy planning data. Physics and Imaging in Radiation Oncology, 22(2022), 91-97. https://doi.org/10.1016/j.phro.2022.05.004.
  • Lopez Da Cruz, PL., Newton, R., Taaffe, D., Singh, F., Lyons-Wall, P., Buffart, L., Tang, C., Hayne, D., Galvao, D. (2022). Interventions for Improving Body Composition in Men with Prostate Cancer: A Systematic Review and Network Meta-analysis. Medicine and Science in Sports and Exercise, 54(5), 728-740. https://doi.org/10.1249/MSS.0000000000002843.
  • Galvao, D., Taaffe, D., Hayne, D., Lopez Da Cruz, PL., Lyons-Wall, P., Tang, C., Chambers, S., Devine, A., Spry, N., Jeffery, E., A S Kudiarasu, C., Joseph, D., Newton, R. (2022). Weight loss for overweight and obese patients with prostate cancer: a study protocol of a randomised trial comparing clinic-based versus Telehealth delivered EXercise and nutrition intervention (the TelEX trial). BMJ Open, 12(6), article number e058899. https://doi.org/10.1136/bmjopen-2021-058899.
  • Schumacher, O., Galvao, D., Taaffe, D., Spry, N., Hayne, D., Tang, C., Chee, R., Newton, R. (2022). Nationwide Industry-Led Community Exercise Program for Men With Locally Advanced, Relapsed, or Metastatic Prostate Cancer on Androgen-Deprivation Therapy. JCO Oncology Practice, 18(8), e1334–e1341. https://doi.org/10.1200/OP.21.00745.
  • Ward, J., Gill, S., Armstrong, K., Fogarty, T., Tan, D., Scott, A., Yahya, A., Dhaliwal, S., Jacques, A., Tang, C. (2022). Randomised controlled trial on the effect of simethicone bowel preparation on rectal variability during image-guided radiation therapy for prostate cancer (SPoRT study). Journal of Medical Imaging and Radiation Oncology, 66(6), 866-873. https://doi.org/10.1111/1754-9485.13404.

Journal Articles

  • Schumacher, O., Galvao, D., Taaffe, D., Spry, N., Joseph, D., Tang, C., Chee, R., Newton, R. (2021). Effect of Exercise Adjunct to Radiation and Androgen Deprivation Therapy on Patient-Reported Treatment Toxicity in Men With Prostate Cancer: A Secondary Analysis of 2 Randomized Controlled Trials. Practical Radiation Oncology, 11(3), 215-225. https://doi.org/10.1016/j.prro.2021.01.005.
  • Lopez Da Cruz, P., Newton, R., Taaffe, D., Singh, F., Buffart, L., Spry, N., Tang, C., Saad, F., Galvao, D. (2021). Associations of fat and muscle mass with overall survival in men with prostate cancer: a systematic review with meta-analysis. Prostate Cancer and Prostatic Diseases, 2021(Article in Press), 12p.. https://doi.org/10.1038/s41391-021-00442-0.
  • Luo, H., Galvao, D., Newton, R., Tang, C., Dean, A., Jasas, K., Johansson, M., Yusoff, I., Spry, N., Taaffe, D. (2021). Feasibility and efficacy of a multi-component exercise medicine program in pancreatic cancer patients undergoing neoadjuvant therapy (the EXPAN trial): study protocol of a dual-centre, two-armed phase I randomised controlled trial. BMJ Open Gastroenterology, 8(1), Article number e000642. https://doi.org/10.1136/bmjgast-2021-000642.
  • Luo, H., Galvao, D., Newton, R., Lopez Da Cruz, P., Tang, C., Fairman, C., Spry, N., Taaffe, D. (2021). Exercise medicine in the management of pancreatic cancer: A systematic review. Pancreas, 50(3), 280-292. https://doi.org/10.1097/MPA.0000000000001753.
  • Schumacher, O., Luo, H., Taaffe, D., Galvao, D., Tang, C., Chee, R., Spry, N., Newton, R. (2021). Effects of exercise during radiotherapy on physical function and treatment-related side effects in men with prostate cancer: A systematic review and meta-analysis. International Journal of Radiation: Oncology - Biology - Physics, 111(3), 716-731. https://doi.org/10.1016/j.ijrobp.2021.06.034.

Journal Articles

  • Kneebone, A., Fraser-Browne, C., Duchesne, G., Fisher, R., Frydenberg, M., Herschtal, A., Williams, S., Brown, C., Delprado, W., Haworth, A., Joseph, D., Martin, J., Matthews, J., Millar, J., Sidhom, M., Spry, N., Tang, C., Turner, S., Wiltshire, K., Woo, H., Davis, I., Lim, T., Pearse, M. (2020). Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial. The Lancet Oncology, 21(10), 1331-1340. https://doi.org/10.1016/S1470-2045(20)30456-3.
  • Nguyen, B., Meehan, K., Pereira, M., Mirzai, B., Lim, SH., Leslie, C., Clark, M., Sader, C., Friedland, P., Lindsay, A., Tang, C., Millward, M., Gray, E., Lim, A. (2020). A comparative study of extracellular vesicle-associated and cell-free DNA and RNA for HPV detection in oropharyngeal squamous cell carcinoma. Scientific Reports, 10(December 2020), Article number 6083. https://doi.org/10.1038/s41598-020-63180-8.

Journal Articles

  • Fairman, C., Kendall, K., Newton, R., Hart, N., Taaffe, D., Chee, R., Tang, C., Galvao, D. (2019). Examining the effects of creatine supplementation in augmenting adaptations to resistance training in prostate cancer patients undergoing androgen deprivation therapy: a randomised, double-blind, placebo-controlled trial. BMJ Open, 9(9), Article number e030080. https://doi.org/10.1136/bmjopen-2019-030080.
  • Newton, R., Christophersen, C., Fairman, C., Hart, N., Taaffe, D., Broadhurst, D., Devine, A., Chee, R., Tang, C., Spry, N., Galvao, D. (2019). Does exercise impact gut microbiota composition in men receiving androgen deprivation therapy for prostate cancer? A single-blinded, two-armed, randomised controlled trial. BMJ Open, 9(4), article no. e024872. https://doi.org/10.1136/bmjopen-2018-024872.
Skip to top of page